These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35822422)

  • 41. Hyperglucagonemia in Pediatric Adiposity Associates With Cardiometabolic Risk Factors but Not Hyperglycemia.
    Stinson SE; Jonsson AE; de Retana Alzola IF; Lund MAV; Frithioff-Bøjsøe C; Aas Holm L; Fonvig CE; Pedersen O; Ängquist L; Sørensen TIA; Holst JJ; Christiansen M; Holm JC; Hartmann B; Hansen T
    J Clin Endocrinol Metab; 2022 May; 107(6):1569-1576. PubMed ID: 35213713
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hyperglucagonemia Does Not Explain the β-Cell Hyperresponsiveness and Insulin Resistance in Dysglycemic Youth Compared With Adults: Lessons From the RISE Study.
    Kahn SE; Mather KJ; Arslanian SA; Barengolts E; Buchanan TA; Caprio S; Ehrmann DA; Hannon TS; Marcovina S; Nadeau KJ; Utzschneider KM; Xiang AH; Edelstein SL; ;
    Diabetes Care; 2021 Sep; 44(9):1961-1969. PubMed ID: 34131047
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Loss of inverse relationship between pulsatile insulin and glucagon secretion in patients with type 2 diabetes.
    Menge BA; Grüber L; Jørgensen SM; Deacon CF; Schmidt WE; Veldhuis JD; Holst JJ; Meier JJ
    Diabetes; 2011 Aug; 60(8):2160-8. PubMed ID: 21677283
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lixisenatide resensitizes the insulin-secretory response to intravenous glucose challenge in people with type 2 diabetes--a study in both people with type 2 diabetes and healthy subjects.
    Becker RH; Stechl J; Msihid J; Kapitza C
    Diabetes Obes Metab; 2014 Sep; 16(9):793-800. PubMed ID: 24521245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis.
    Bock G; Chittilapilly E; Basu R; Toffolo G; Cobelli C; Chandramouli V; Landau BR; Rizza RA
    Diabetes; 2007 Jun; 56(6):1703-11. PubMed ID: 17384334
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM.
    Rachman J; Payne MJ; Levy JC; Barrow BA; Holman RR; Turner RC
    Diabetes Care; 1998 May; 21(5):810-6. PubMed ID: 9589246
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
    Gutniak M; Grill V; Efendić S
    J Clin Endocrinol Metab; 1986 Jan; 62(1):77-83. PubMed ID: 2866196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Deconvolution analysis of rapid insulin pulses before and after six weeks of continuous subcutaneous administration of glucagon-like peptide-1 in elderly patients with type 2 diabetes.
    Meneilly GS; Veldhuis JD; Elahi D
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6251-6. PubMed ID: 16091500
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications.
    Dunning BE; Gerich JE
    Endocr Rev; 2007 May; 28(3):253-83. PubMed ID: 17409288
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of hepatic insulin action in obese type 2 diabetic patients.
    Staehr P; Hother-Nielsen O; Levin K; Holst JJ; Beck-Nielsen H
    Diabetes; 2001 Jun; 50(6):1363-70. PubMed ID: 11375337
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance.
    Bock G; Dalla Man C; Campioni M; Chittilapilly E; Basu R; Toffolo G; Cobelli C; Rizza R
    Diabetes; 2006 Dec; 55(12):3536-49. PubMed ID: 17130502
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Normal secretion and action of the gut incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in young men with low birth weight.
    Schou JH; Pilgaard K; Vilsbøll T; Jensen CB; Deacon CF; Holst JJ; Vølund A; Madsbad S; Vaag AA
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4912-9. PubMed ID: 15899957
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fasting until noon triggers increased postprandial hyperglycemia and impaired insulin response after lunch and dinner in individuals with type 2 diabetes: a randomized clinical trial.
    Jakubowicz D; Wainstein J; Ahren B; Landau Z; Bar-Dayan Y; Froy O
    Diabetes Care; 2015 Oct; 38(10):1820-6. PubMed ID: 26220945
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glucose regulation in non-insulin-dependent diabetes mellitus. Interaction between pancreatic islets and the liver.
    Halter JB; Ward WK; Porte D; Best JD; Pfeifer MA
    Am J Med; 1985 Aug; 79(2B):6-12. PubMed ID: 2863979
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mixed Meal and Intravenous L-Arginine Tests Both Stimulate Incretin Release Across Glucose Tolerance in Man: Lack of Correlation with β Cell Function.
    Ruetten H; Gebauer M; Raymond RH; Calle RA; Cobelli C; Ghosh A; Robertson RP; Shankar SS; Staten MA; Stefanovski D; Vella A; Wright K; Fryburg DA;
    Metab Syndr Relat Disord; 2018 Oct; 16(8):406-415. PubMed ID: 30117761
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diabetes-associated common genetic variation and its association with GLP-1 concentrations and response to exogenous GLP-1.
    Smushkin G; Sathananthan M; Sathananthan A; Dalla Man C; Micheletto F; Zinsmeister AR; Cobelli C; Vella A
    Diabetes; 2012 May; 61(5):1082-9. PubMed ID: 22461567
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin secretion and action and the response of endogenous glucose production to a lack of glucagon suppression in nondiabetic subjects.
    Adams JD; Egan AM; Laurenti MC; Schembri Wismayer D; Bailey KR; Cobelli C; Dalla Man C; Vella A
    Am J Physiol Endocrinol Metab; 2021 Nov; 321(5):E728-E736. PubMed ID: 34658253
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of acute hyperglycemia in human sepsis on inflammatory cytokine and counterregulatory hormone concentrations.
    Yu WK; Li WQ; Li N; Li JS
    World J Gastroenterol; 2003 Aug; 9(8):1824-7. PubMed ID: 12918129
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
    Gerich JE; Langlois M; Noacco C; Lorenzi M; Karam JH; Korsham PH
    J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.